Health Condition 1: - Health Condition 2: R478- Other speech disturbances
Conditions
Interventions
Intervention1: triamcinolone acetonide and hyaluronidase: After allocation of the patients, Group B patients will be treated with intralesional injection of the combination of Triamcinolone Acetonide
Sponsors
Dr Ajay Kumar
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient above the age of 17 years to 65 years. 2. Patients clinically diagnosed with grade II and III OSMF patients (Clinical staging by Laiââ?¬•s, 1995). 3. Patients who had not undergone any treatment for OSMF in the past 1 year. 4. Cooperative patients. 5. Patients without any systemic illness. 6. Patients who were willing to quit gutkha, arecanut and/or tobacco chewing habit. 7. Patients who agreed for regular follow ups.
Exclusion criteria
Exclusion criteria: 1. OSMF patients with coexisting uncontrolled systemic illness. 2. Patients who had received previous treatment. 3. Patients with other mucosal/potentially medically disorders such as leukoplakia or lichen planus. 4. Patients with history of drug allergy. 5. Pregnant or breastfeeding women. 6. Patients not consenting to participate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Burning sensation 2.Mouth opening 3 cheek flexibility Timepoint: burning sensation in terms of visual analog scale will be measured at baseline and after every week of follow up for 4 weeks . mouth opening and cheek flexibility in terms of mm will be recorded at baseline and after each week for 4 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Cheek flexibility Timepoint: 1.Increase of Cheek flexibility in 2nd and 3rd visit | — |
Countries
India
Contacts
Public ContactDr Ajay Kumar
Faculty of dental sciences,ims,bhu
Outcome results
None listed